Amicogen Statistics

Total Valuation

Amicogen has a market cap or net worth of KRW 196.79 billion. The enterprise value is 318.26 billion.

Market Cap	196.79B
Enterprise Value	318.26B

Important Dates

The last earnings date was Sunday, March 16, 2025.

Earnings Date	Mar 16, 2025
Ex-Dividend Date	n/a

Share Statistics

Amicogen has 54.82 million shares outstanding. The number of shares has increased by 37.75% in one year.

Current Share Class	n/a
Shares Outstanding	54.82M
Shares Change (YoY)	+37.75%
Shares Change (QoQ)	-0.07%
Owned by Insiders (%)	4.96%
Owned by Institutions (%)	6.28%
Float	52.10M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.14
PB Ratio	1.61
P/TBV Ratio	1.61
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 72.49, with an EV/FCF ratio of -5.22.

EV / Earnings	-6.03
EV / Sales	1.83
EV / EBITDA	72.49
EV / EBIT	n/a
EV / FCF	-5.22

Financial Position

The company has a current ratio of 0.98, with a Debt / Equity ratio of 0.91.

Current Ratio	0.98
Quick Ratio	0.83
Debt / Equity	0.91
Debt / EBITDA	27.32
Debt / FCF	-1.97
Interest Coverage	-0.93

Financial Efficiency

Return on equity (ROE) is -28.90% and return on invested capital (ROIC) is -1.92%.

Return on Equity (ROE)	-28.90%
Return on Assets (ROA)	-1.57%
Return on Invested Capital (ROIC)	-1.92%
Return on Capital Employed (ROCE)	-4.68%
Revenue Per Employee	771.58M
Profits Per Employee	-234.63M
Employee Count	225
Asset Turnover	0.46
Inventory Turnover	4.30

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -59.11% in the last 52 weeks. The beta is 1.05, so Amicogen's price volatility has been similar to the market average.

Beta (5Y)	1.05
52-Week Price Change	-59.11%
50-Day Moving Average	3,805.60
200-Day Moving Average	4,555.78
Relative Strength Index (RSI)	45.79
Average Volume (20 Days)	242,971

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Amicogen had revenue of KRW 173.60 billion and -52.79 billion in losses. Loss per share was -961.00.

Revenue	173.60B
Gross Profit	50.21B
Operating Income	-9.56B
Pretax Income	-50.54B
Net Income	-52.79B
EBITDA	4.39B
EBIT	-9.56B
Loss Per Share	-961.00

Full Income Statement

Balance Sheet

The company has 8.45 billion in cash and 119.97 billion in debt, giving a net cash position of -111.52 billion or -2,034.37 per share.

Cash & Cash Equivalents	8.45B
Total Debt	119.97B
Net Cash	-111.52B
Net Cash Per Share	-2,034.37
Equity (Book Value)	132.45B
Book Value Per Share	2,234.65
Working Capital	-2.06B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -13.34 billion and capital expenditures -47.68 billion, giving a free cash flow of -61.02 billion.

Operating Cash Flow	-13.34B
Capital Expenditures	-47.68B
Free Cash Flow	-61.02B
FCF Per Share	-1,113.12

Full Cash Flow Statement

Margins

Gross margin is 28.92%, with operating and profit margins of -5.51% and -30.41%.

Gross Margin	28.92%
Operating Margin	-5.51%
Pretax Margin	-29.11%
Profit Margin	-30.41%
EBITDA Margin	2.53%
EBIT Margin	-5.51%
FCF Margin	n/a

Dividends & Yields

Amicogen does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-37.75%
Shareholder Yield	-37.75%
Earnings Yield	-26.83%
FCF Yield	-31.01%

Stock Splits

The last stock split was on December 13, 2023. It was a forward split with a ratio of 2.

Last Split Date	Dec 13, 2023
Split Type	Forward
Split Ratio	2

Scores

Amicogen has an Altman Z-Score of 1.46. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.46
Piotroski F-Score	n/a